Your browser doesn't support javascript.
loading
Interferon-ß acts directly on T cells to prolong allograft survival by enhancing regulatory T cell induction through Foxp3 acetylation.
Fueyo-González, Francisco; McGinty, Mitchell; Ningoo, Mehek; Anderson, Lisa; Cantarelli, Chiara; Demir, Markus; Llaudó, Inés; Purroy, Carolina; Marjanovic, Nada; Heja, David; Sealfon, Stuart C; Heeger, Peter S; Cravedi, Paolo; Fribourg, Miguel.
Afiliação
  • Fueyo-González F; Division of Nephrology, Department of Medicine, Translational Transplant Research Center, Icahn School of Medicine at Mount Sinai, New York City, NY, USA; Immunology Institute Icahn School of Medicine at Mount Sinai, New York City, NY, USA.
  • McGinty M; Carter Immunology Center, University of Virginia, Charlottesville, VA 22903, USA.
  • Ningoo M; Division of Nephrology, Department of Medicine, Translational Transplant Research Center, Icahn School of Medicine at Mount Sinai, New York City, NY, USA; Immunology Institute Icahn School of Medicine at Mount Sinai, New York City, NY, USA.
  • Anderson L; Division of Nephrology, Department of Medicine, Translational Transplant Research Center, Icahn School of Medicine at Mount Sinai, New York City, NY, USA; Immunology Institute Icahn School of Medicine at Mount Sinai, New York City, NY, USA.
  • Cantarelli C; UO Nefrologia, Azienda Ospedaliero-Universitaria Parma, Parma, Italy.
  • Andrea Angeletti; Division of Nephrology, Dialysis, Transplantation, IRCCS Giannina Gaslini, Genoa, Italy.
  • Demir M; Department of Anesthesiology, University of Cologne, Cologne, Germany.
  • Llaudó I; Division of Nephrology, Department of Medicine, Translational Transplant Research Center, Icahn School of Medicine at Mount Sinai, New York City, NY, USA; Immunology Institute Icahn School of Medicine at Mount Sinai, New York City, NY, USA.
  • Purroy C; Department of Nephrology, Complejo Hospitalario de Navarra, Navarra, Spain.
  • Marjanovic N; Immunology Institute Icahn School of Medicine at Mount Sinai, New York City, NY, USA; Department of Neurology, Icahn School of Medicine at Mount Sinai, New York City, NY, USA.
  • Heja D; Division of Nephrology, Department of Medicine, Translational Transplant Research Center, Icahn School of Medicine at Mount Sinai, New York City, NY, USA; Immunology Institute Icahn School of Medicine at Mount Sinai, New York City, NY, USA.
  • Sealfon SC; Immunology Institute Icahn School of Medicine at Mount Sinai, New York City, NY, USA; Department of Neurology, Icahn School of Medicine at Mount Sinai, New York City, NY, USA.
  • Heeger PS; Division of Nephrology, Department of Medicine, Translational Transplant Research Center, Icahn School of Medicine at Mount Sinai, New York City, NY, USA; Immunology Institute Icahn School of Medicine at Mount Sinai, New York City, NY, USA.
  • Cravedi P; Division of Nephrology, Department of Medicine, Translational Transplant Research Center, Icahn School of Medicine at Mount Sinai, New York City, NY, USA; Immunology Institute Icahn School of Medicine at Mount Sinai, New York City, NY, USA.
  • Fribourg M; Division of Nephrology, Department of Medicine, Translational Transplant Research Center, Icahn School of Medicine at Mount Sinai, New York City, NY, USA; Immunology Institute Icahn School of Medicine at Mount Sinai, New York City, NY, USA. Electronic address: miguel.fribourg@mssm.edu.
Immunity ; 55(3): 459-474.e7, 2022 03 08.
Article em En | MEDLINE | ID: mdl-35148827

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Interferon beta / Linfócitos T Reguladores Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Interferon beta / Linfócitos T Reguladores Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article